These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 19962619)

  • 1. The Disease Activity Score and the EULAR response criteria.
    Fransen J; van Riel PL
    Rheum Dis Clin North Am; 2009 Nov; 35(4):745-57, vii-viii. PubMed ID: 19962619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between the American College of Rheumatology pediatric response measures and the continuous measures of disease activity used in adult rheumatoid arthritis: a secondary analysis of clinical trial data from children with polyarticular-course juvenile idiopathic arthritis.
    Ringold S; Chon Y; Singer NG
    Arthritis Rheum; 2009 Dec; 60(12):3776-83. PubMed ID: 19950286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence of clinical remission in RA patients treated with anti-TNF: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry.
    de Punder YM; Fransen J; Kievit W; Houtman PM; Visser H; van de Laar MA; van Riel PL
    Rheumatology (Oxford); 2012 Sep; 51(9):1610-7. PubMed ID: 22539487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term outcome after anti-tumor necrosis factor-alpha therapy in rheumatoid arthritis: do we need to revise our assessment criteria?
    El Miedany Y; Youssef SS; El Gaafary M
    J Rheumatol; 2006 Mar; 33(3):490-7. PubMed ID: 16511918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Disease Activity Score and the EULAR response criteria.
    Fransen J; van Riel PL
    Clin Exp Rheumatol; 2005; 23(5 Suppl 39):S93-9. PubMed ID: 16273792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association with joint damage and physical functioning of nine composite indices and the 2011 ACR/EULAR remission criteria in rheumatoid arthritis.
    Klarenbeek NB; Koevoets R; van der Heijde DM; Gerards AH; Ten Wolde S; Kerstens PJ; Huizinga TW; Dijkmans BA; Allaart CF
    Ann Rheum Dis; 2011 Oct; 70(10):1815-21. PubMed ID: 21813548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial.
    Lambert CM; Sandhu S; Lochhead A; Hurst NP; McRorie E; Dhillon V
    Arthritis Rheum; 2004 Feb; 50(2):364-71. PubMed ID: 14872477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity indices in rheumatoid arthritis.
    Villaverde V; Balsa A; Cantalejo M; Fernández-Prada M; Madero MR; Muñoz-Fernández S; Gijón-Baños J; Martín-Mola E
    J Rheumatol; 2000 Nov; 27(11):2576-81. PubMed ID: 11093436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of response criteria to evaluate therapeutic response in patients with juvenile idiopathic arthritis treated with methotrexate and/or anti-tumor necrosis factor alpha agents.
    Lurati A; Pontikaki I; Teruzzi B; Desiati F; Gerloni V; Gattinara M; Cimaz R; Fantini F
    Arthritis Rheum; 2006 May; 54(5):1602-7. PubMed ID: 16646003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Disease Activity Score (DAS) and the Disease Activity Score using 28 joint counts (DAS28) in the management of rheumatoid arthritis.
    van Riel PL; Renskers L
    Clin Exp Rheumatol; 2016; 34(5 Suppl 101):S40-S44. PubMed ID: 27762189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can RAPID3, an index without formal joint counts or laboratory tests, serve to guide rheumatologists in tight control of rheumatoid arthritis in usual clinical care?
    Pincus T
    Bull NYU Hosp Jt Dis; 2009; 67(3):254-66. PubMed ID: 19852747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of leflunomide and predisposing factors for treatment response in patients with active rheumatoid arthritis: RELIEF 6-month data.
    Dougados M; Emery P; Lemmel EM; de la Serna R; Zerbini CA; Brin S; van Riel P
    J Rheumatol; 2003 Dec; 30(12):2572-9. PubMed ID: 14719196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response criteria for rheumatoid arthritis in clinical practice: how useful are they?
    Gülfe A; Geborek P; Saxne T
    Ann Rheum Dis; 2005 Aug; 64(8):1186-9. PubMed ID: 15760931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease activity measurement of rheumatoid arthritis: Comparison of the simplified disease activity index (SDAI) and the disease activity score including 28 joints (DAS28) in daily routine.
    Leeb BF; Andel I; Sautner J; Bogdan M; Maktari A; Nothnagl T; Rintelen B
    Arthritis Rheum; 2005 Feb; 53(1):56-60. PubMed ID: 15696565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The development of the disease activity score (DAS) and the disease activity score using 28 joint counts (DAS28).
    van Riel PL
    Clin Exp Rheumatol; 2014; 32(5 Suppl 85):S-65-74. PubMed ID: 25365092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states.
    Aletaha D; Ward MM; Machold KP; Nell VP; Stamm T; Smolen JS
    Arthritis Rheum; 2005 Sep; 52(9):2625-36. PubMed ID: 16142705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An index of the three core data set patient questionnaire measures distinguishes efficacy of active treatment from that of placebo as effectively as the American College of Rheumatology 20% response criteria (ACR20) or the Disease Activity Score (DAS) in a rheumatoid arthritis clinical trial.
    Pincus T; Strand V; Koch G; Amara I; Crawford B; Wolfe F; Cohen S; Felson D
    Arthritis Rheum; 2003 Mar; 48(3):625-30. PubMed ID: 12632413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validity and reliability problems with patient global as a component of the ACR/EULAR remission criteria as used in clinical practice.
    Masri KR; Shaver TS; Shahouri SH; Wang S; Anderson JD; Busch RE; Michaud K; Mikuls TR; Caplan L; Wolfe F
    J Rheumatol; 2012 Jun; 39(6):1139-45. PubMed ID: 22589262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Standardisation proposal for monitoring rheumatoid arthritis patients in Croatia].
    Pavlović R
    Reumatizam; 2004; 51(1):12-8. PubMed ID: 15554366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adsorptive granulocyte/monocyte apheresis for the treatment of refractory rheumatoid arthritis: an open pilot multicentre trial.
    Sanmartí R; Marsal S; Valverde J; Casado E; Lafuente R; Kashiwagi N; Rodriguez-Cros JR; Erra A; Reina D; Gratacós J
    Rheumatology (Oxford); 2005 Sep; 44(9):1140-4. PubMed ID: 15927997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.